February 28, 2019
343rd Edition – February 26, 2019
BioHealth Innovation If you are having trouble viewing this email, please click here February 26,…
February 28, 2019
342nd Edition – February 20, 2019
BioHealth Innovation If you are having trouble viewing this email, please click here February 20,…
February 28, 2019
341st Edition – February 12, 2019
BioHealth Innovation If you are having trouble viewing this email, please click here February 12,…
February 25, 2019
Top 10 Immuno-Oncology Startups – GEN – Genetic Engineering and Biotechnology News
GlaxoSmithKline (GSK)’s recently announced $4.2 billion partnership to co-develop and co-commercialize Merck KGaA, Darmstadt’s cancer…
February 25, 2019
Danaher acquires GE Biopharma for $21.4B – Washington Business Journal
The deal is expected to close in the fourth quarter of this year. (more…)
February 25, 2019
RoosterBio Announces Plans to Expand Facility in Frederick, MD
RoosterBio, Inc, a privately held regenerative medicine manufacturing platform technology company announced plans today to…
February 25, 2019
Antidote Therapeutics teams up with National Cancer Institute, seeks funding for nicotine-blocking drug candidate – Washington Business Journal
Matt Kalnik wants to make smoking less addictive. His clinical-stage company, Gaithersburg-based Antidote Therapeutics Inc.,…
February 25, 2019
Maryland Momentum Fund accepting applications | Office of Technology Commercialization
The Maryland Momentum Fund is a newly-created mechanism for investing in promising early stage companies…
February 25, 2019
Kauffman Indicators of Entrepreneurship
The Kauffman Indicators of Entrepreneurship offers in-depth measures, reports, and accompanying interactive data visualizations that…
February 25, 2019
MPM Capital raises $400M in seventh venture fund – MedCity News
A life sciences-focused venture capital firm based near Boston has raised more than one-third of…